Sana Biotechnology SANA
NASDAQ SANA
$3.85 -0.07 (-1.79%)
As of: Sep 4, 2026 · 3:59 PM EDT

Sana Biotechnology (SANA) Change in Acquisitions & Divestments (2020 - 2026)

Sana Biotechnology (SANA) posted Change in Acquisitions & Divestments of $55.1 million for Q1 2026, up 178.11% sequentially from $19.8 million in Q4 2025, and up 203.09% YoY from $18.2 million in Q1 2025.

Analysis

Sana Biotechnology (SANA) Change in Acquisitions & Divestments (2020 - 2026) Analysis & Trends

Sana Biotechnology has reported Change in Acquisitions & Divestments for 7 years, with the latest figure at $55.1 million in Q1 2026.

  • Quarterly Change in Acquisitions & Divestments rose 203.09% year-over-year to $55.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $83.5 million (down 65.53% YoY) and the FY2025 annual result came in at $46.6 million, down 83.19% from the prior year.
  • Change in Acquisitions & Divestments rose to $55.1 million in Q1 2026 per SANA's latest filing, from $19.8 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $113.9 million in Q3 2023 and troughed at $1.4 million in Q3 2025.
  • A 5-year average of $61.1 million and a median of $55.5 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
  • The sharpest annual moves came in 2022 and 2025: Change in Acquisitions & Divestments jumped 727.67% in 2022, then plunged 98.28% in 2025.
  • Over 5 years, Change in Acquisitions & Divestments stood at $108.1 million in 2022, then tumbled by 48.69% to $55.5 million in 2023, then climbed by 9.22% to $60.6 million in 2024, then sank by 67.33% to $19.8 million in 2025, then jumped by 178.11% to $55.1 million in 2026.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $55.1 million, $19.8 million, and $1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Sana Biotechnology 1.14 Bn 1.14 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.75 Mn
Mar 31, 2026 55.07 Mn
Dec 31, 2025 19.80 Mn
Sep 30, 2025 1.41 Mn
Jun 30, 2025 7.19 Mn
Mar 31, 2025 18.17 Mn
Dec 31, 2024 60.60 Mn
Sep 30, 2024 81.84 Mn
Jun 30, 2024 81.50 Mn
Mar 31, 2024 53.01 Mn
Dec 31, 2023 55.48 Mn
Sep 30, 2023 113.93 Mn
Jun 30, 2023 95.04 Mn
Mar 31, 2023 85.33 Mn
Dec 31, 2022 108.14 Mn
Sep 30, 2022 53.83 Mn
Jun 30, 2022 102.41 Mn
Mar 31, 2022 45.75 Mn
Dec 31, 2021 13.07 Mn
Sep 30, 2021 71.05 Mn